Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almeida-Porada, G.
Right arrow Articles by Zanjani, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almeida-Porada, G.
Right arrow Articles by Zanjani, E. D.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Transplantation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 11 (June 1), 2000: pp. 3620-3627

Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation

Graça Almeida-Porada, Christopher D. Porada, Nam Tran, and Esmail D. Zanjani

Department of Veterans Affairs Medical Center, University of Nevada Reno, Reno, NV.

Both in utero and postnatal hematopoietic stem cell (HSC) transplantation would benefit from the development of approaches that produce increased levels of engraftment or a reduction in the period of time required for reconstitution. We used the in utero model of human-sheep HSC transplantation to investigate ways of improving engraftment and differentiation of donor cells after transplantation. We hypothesized that providing a more suitable microenvironment in the form of human stromal cell progenitors simultaneously with the transplanted human HSC would result in higher rates of engraftment or differentiation of the human cells in this xenogeneic model. The results presented here demonstrate that the cotransplantation of both autologous and allogeneic human bone marrow-derived stromal cell progenitors resulted in an enhancement of long-term engraftment of human cells in the bone marrow of the chimeric animals and in earlier and higher levels of donor cells in circulation both during gestation and after birth. By using marked stromal cells, we have also demonstrated that injected stromal cells alone engraft and remain functional within the sheep hematopoietic microenvironment. Application of this method to clinical HSC transplantation could potentially lead to increased levels of long-term engraftment, a reduction in the time for hematopoietic reconstitution, and a means of delivery of foreign genes to the hematopoietic system.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
X.-Y. Wang, Y. Lan, W.-Y. He, L. Zhang, H.-Y. Yao, C.-M. Hou, Y. Tong, Y.-L. Liu, G. Yang, X.-D. Liu, et al.
Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos
Blood, February 15, 2008; 111(4): 2436 - 2443.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Bocelli-Tyndall, L. Bracci, G. Spagnoli, A. Braccini, M. Bouchenaki, R. Ceredig, V. Pistoia, I. Martin, and A. Tyndall
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
Rheumatology, March 1, 2007; 46(3): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. M. van Laar and A. Tyndall
Adult stem cells in the treatment of autoimmune diseases
Rheumatology, October 1, 2006; 45(10): 1187 - 1193.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Blood, September 15, 2006; 108(6): 2114 - 2120.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Zeng, M.-j. Chen, D. A. Baldwin, Z.-j. Gong, J.-b. Yan, H. Qian, J. Wang, X. Jiang, Z.-r. Ren, D. Sun, et al.
Multiorgan engraftment and differentiation of human cord blood CD34+Lin- cells in goats assessed by gene expression profiling
PNAS, May 16, 2006; 103(20): 7801 - 7806.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. C. Mendes, C. Robin, and E. Dzierzak
Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny
Development, March 1, 2005; 132(5): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bensidhoum, A. Chapel, S. Francois, C. Demarquay, C. Mazurier, L. Fouillard, S. Bouchet, J. M. Bertho, P. Gourmelon, J. Aigueperse, et al.
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment
Blood, May 1, 2004; 103(9): 3313 - 3319.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. S. in `t Anker, S. A. Scherjon, C. Kleijburg-van der Keur, W. A. Noort, F. H. J. Claas, R. Willemze, W. E. Fibbe, and H. H. H. Kanhai
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation
Blood, August 15, 2003; 102(4): 1548 - 1549.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. D. Ho and M. Punzel
Hematopoietic stem cells: can old cells learn new tricks?
J. Leukoc. Biol., May 1, 2003; 73(5): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P. D. Longoni, P. Matteucci, S. Grisanti, and A. M. Gianni
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Blood, May 15, 2002; 99(10): 3838 - 3843.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, R. T. McElmurry, C. J. Lees, D. E. Harrison, and B. R. Blazar
Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients
Blood, March 1, 2002; 99(5): 1870 - 1872.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Blood, October 15, 2001; 98(8): 2396 - 2402.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Minguell, A. Erices, and P. Conget
Mesenchymal Stem Cells
Experimental Biology and Medicine, June 1, 2001; 226(6): 507 - 520.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Cilloni, C. Carlo-Stella, F. Falzetti, G. Sammarelli, E. Regazzi, S. Colla, V. Rizzoli, F. Aversa, M. F. Martelli, and A. Tabilio
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation
Blood, November 15, 2000; 96(10): 3637 - 3643.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020